Lysosomes as a therapeutic target

SR Bonam, F Wang, S Muller - Nature reviews Drug discovery, 2019 - nature.com
Lysosomes are membrane-bound organelles with roles in processes involved in degrading
and recycling cellular waste, cellular signalling and energy metabolism. Defects in genes …

Exploring pro-inflammatory immunological mediators: Unraveling the mechanisms of neuroinflammation in lysosomal storage diseases

MK Pandey - Biomedicines, 2023 - mdpi.com
Lysosomal storage diseases are a group of rare and ultra-rare genetic disorders caused by
defects in specific genes that result in the accumulation of toxic substances in the lysosome …

GM1 gangliosidosis type II: Results of a 10-year prospective study

P D'Souza, C Farmer, JM Johnston, ST Han… - Genetics in …, 2024 - Elsevier
Abstract Purpose GM1 gangliosidosis (GM1) a lysosomal disorder caused by pathogenic
variants in GLB1, is characterized by relentless neurodegeneration. There are no approved …

[HTML][HTML] GLB1-related disorders

DS Regier, CJ Tifft, CE Rothermel - 2021 - europepmc.org
GLB1-related disorders comprise two phenotypically distinct lysosomal storage disorders:
GM1 gangliosidosis and mucopolysaccharidosis type IVB (MPS IVB). The phenotype of GM1 …

The natural history of Type 1 infantile GM1 gangliosidosis: A literature-based meta-analysis

FM Lang, P Korner, M Harnett, A Karunakara… - Molecular genetics and …, 2020 - Elsevier
Introduction Type 1 GM1 gangliosidosis is an ultra-rare, rapidly fatal lysosomal storage
disorder, with life expectancy of< 3 years of age. To date, only one prospective natural …

The clinical and molecular spectrum of GM1 gangliosidosis

L Arash-Kaps, K Komlosi, M Seegräber… - The Journal of …, 2019 - Elsevier
Objective To evaluate the clinical presentation of patients with GM1 gangliosidosis and to
determine whether specific clinical or biochemical signs could lead to a prompt diagnosis …

A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy

S Liu, Y Feng, Y Huang, X Jiang… - Experimental …, 2021 - journals.sagepub.com
GM1 gangliosidosis is a rare lysosomal storage disease caused by a deficiency of β-
galactosidase due to mutations in the GLB1 gene. We established a C57BL/6 mouse model …

[HTML][HTML] The juvenile gangliosidoses: A timeline of clinical change

KE King, S Kim, CB Whitley, JR Jarnes-Utz - Molecular genetics and …, 2020 - Elsevier
Background The gangliosidoses are rare inherited diseases that result in pathologic
accumulation of gangliosides in the central nervous system and other tissues, leading to …

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content

R Tonin, A Caciotti, E Procopio, R Fischetto… - Scientific Reports, 2019 - nature.com
GM1 ganglioside, a monosialic glycosphingolipid and a crucial component of plasma
membranes, accumulates in lysosomal storage disorders, primarily in GM1 gangliosidosis …

Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes

P Borges, G Pasqualim, R Giugliani, F Vairo… - Orphanet Journal of …, 2020 - Springer
Background In this study, the prevalence of different types of mucopolysaccharidoses (MPS)
was estimated based on data from the exome aggregation consortium (ExAC) and the …